Cardiogenic shock complicating acute myocardial infarction - Etiologies, management and outcome: A report from the SHOCK Trial Registry

被引:467
作者
Hochman, JS
Buller, CE
Sleeper, LA
Boland, J
Dzavik, V
Sanborn, TA
Godfrey, E
White, HD
Lim, J
LeJemtel, T
机构
[1] Columbia Univ, St Lukes Roosevelt Hosp Ctr, New York, NY 10025 USA
[2] Vancouver Hosp & Hlth Sci Ctr, Vancouver, BC V5Z 1M9, Canada
[3] New England Res Inst, Watertown, MA 02172 USA
[4] CHR Citadelle, Dept Cardiol, Liege, Belgium
[5] Univ Alberta, Div Cardiol, Edmonton, AB, Canada
[6] New York Cornell Med Ctr, New York, NY USA
[7] Green Lane Hosp, Auckland 3, New Zealand
[8] Albert Einstein Med Ctr, Coll Med, New York, NY USA
关键词
D O I
10.1016/S0735-1097(00)00879-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This SHOCK Study report seeks to provide an overview of patients with cardiogenic shock (CS) complicating acute myocardial infarction (MI) and the outcome with various treatments. The outcome of patients undergoing revascularization in the SHOCK Trial Registry and SHOCK Trial are compared. BACKGROUND Cardiogenic shock is the leading cause of death in patients hospitalized for acute MI. The randomized SHOCK Trial reported improved six-month survival with early revascularization. METHODS Patients with CS complicating acute MI who were not enrolled in the concurrent randomized trial were registered. Patient characteristics were recorded as were procedures and vital status at hospital discharge. RESULTS Between April 1993 and August 1997, 1,190 patients with CS were registered and 232 were randomized in the SHOCK Trial. Predominant left ventricular failure (78.5%) was most common, with isolated right ventricular shock in 2.8%, severe mitral regurgitation in 6.9%, ventricular septal rupture in 3.9% and tamponade in 1.4%. In-hospital Registry mortality was 60%, with ventricular septal rupture associated with a significantly higher mortality (87.3%) than all other categories (p < 0.01). The risk profile and mortality were lower for Registry patients who were managed with thrombolycic therapy and/or intra-aortic balloon counterpulsation, coronary angiography, angioplasty and/or coronary artery bypass surgery. After adjusting for these differences, the extent to which survival was improved with early revascularization was similar to that observed in the randomized SHOCK Trial. CONCLUSIONS In this prospective Registry the etiology of CS was a mechanical complication in 12%. The similarity of the beneficial treatment effect in patients undergoing early revascularization in the SHOCK Trial Registry and SHOCK Trial provides strong support for the generalizability of the SHOCK Trial results. (J Am Coil Cardiol 2000;36:1063-70) (C) 2000 by the American College of Cardiology.
引用
收藏
页码:1063 / 1070
页数:8
相关论文
共 35 条
  • [1] [Anonymous], 1988, LANCET, V2, P349
  • [2] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
    APPLEBY, P
    BAIGENT, C
    COLLINS, R
    FLATHER, M
    PARISH, S
    PETO, R
    BELL, P
    HALLS, H
    MEAD, G
    DIAZ, R
    PAOLASSO, E
    PAVIOTTI, C
    ROMERO, G
    CAMPBELL, T
    OROURKE, MF
    THOMPSON, P
    LESAFFRE, E
    VANDEWERF, F
    VERSTRAETE, M
    ARMSTRONG, PW
    CAIRNS, JA
    MORAN, C
    TURPIE, AG
    YUSUF, S
    GRANDE, P
    HEIKKILA, J
    KALA, R
    BASSAND, JP
    BOISSEL, JP
    BROCHIER, M
    LEIZOROVICZ, A
    BRUGGEMANN, T
    KARSCH, KR
    KASPER, W
    LAMMERTS, D
    NEUHAUS, KL
    MEYER, J
    SCHRODER, R
    VONESSEN, R
    SARAN, RK
    ARDISSINO, D
    BONADUCE, D
    BRUNELLI, C
    CERNIGLIARO, C
    FORESTI, A
    FRANZOSI, MG
    GUIDUCCI, D
    MAGGIONI, A
    MAGNANI, B
    MATTIOLI, G
    [J]. LANCET, 1994, 343 (8893) : 311 - 322
  • [3] Use of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock
    Barron, HV
    Pirzada, SR
    Lomnitz, DJ
    Every, NR
    Gore, JM
    Chou, TM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 135A - 135A
  • [4] A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction
    Becker, RC
    Gore, JM
    Lambrew, C
    Weaver, WD
    Rubison, RM
    French, WJ
    Tiefenbrunn, AJ
    Bowlby, LJ
    Rogers, WJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (06) : 1321 - 1326
  • [5] BOLOOKI H, 1989, CIRCULATION, V79, P37
  • [6] CARDIOGENIC-SHOCK AFTER ACUTE MYOCARDIAL-INFARCTION - INCIDENCE AND MORTALITY FROM A COMMUNITY-WIDE PERSPECTIVE, 1975 TO 1988
    GOLDBERG, RJ
    GORE, JM
    ALPERT, JS
    OSGANIAN, V
    DEGROOT, J
    BADE, J
    CHEN, Z
    FRID, D
    DALEN, JE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (16) : 1117 - 1122
  • [7] Temporal trends in cardiogenic shock complicating acute myocardial infarction
    Goldberg, RJ
    Samad, NA
    Yarzebski, J
    Gurwitz, J
    Bigelow, C
    Gore, JM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (15) : 1162 - 1168
  • [8] *GRUPP IT STUD STR, 1986, LANCET, P397
  • [9] GUYTON RA, 1987, CIRCULATION, V76, P22
  • [10] THE IN-HOSPITAL DEVELOPMENT OF CARDIOGENIC-SHOCK AFTER MYOCARDIAL-INFARCTION - INCIDENCE, PREDICTORS OF OCCURRENCE, OUTCOME AND PROGNOSTIC FACTORS
    HANDS, ME
    RUTHERFORD, JD
    MULLER, JE
    DAVIES, G
    STONE, PH
    PARKER, C
    BRAUNWALD, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (01) : 40 - 46